Plasmapheresis in cast nephropathy
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Nephrology,Internal Medicine
Reference37 articles.
1. Cancer Statistics, 2009
2. Improved survival in multiple myeloma and the impact of novel therapies
3. Achieving an Early Myeloma Response in Patients With Kidney Impairment
4. Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis
5. Novel approaches for reducing free light chains in patients with myeloma kidney
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Onconephrology: Acute kidney injury in cancer patients;Ukrainian Journal of Nephrology and Dialysis;2023-06-19
2. Onconephrology: The intersections between the kidney and cancer;CA: A Cancer Journal for Clinicians;2020-08-27
3. Impact of hemodialysis on the prognosis of multiple myeloma: A nationwide population‑based study and single‑institute analysis;Oncology Letters;2018-05-31
4. Serum Free Light Chains Removal by HFR Hemodiafiltration in Patients with Multiple Myeloma and Acute Kidney Injury: a Case Series;Kidney and Blood Pressure Research;2018
5. Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology;Journal of Nephrology;2016-10-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3